Birzeit Pharmaceuticals Company (PEX:BPC)

PEX:BPC Revenue

Birzeit Pharmaceuticals Company had revenue of $9.71M USD in the quarter ending June 30, 2026, a decrease of -20.80%. This brings the company's revenue in the last twelve months to $46.66M, up 2.08% year-over-year. In the year 2025, Birzeit Pharmaceuticals Company had annual revenue of $47.96M with 17.98% growth.

• Revenue (ttm): $46.66M
• Revenue Growth: +2.08%
• P/S Ratio: 3.00
• Revenue / Employee: $125.42K
• Employees: 372
• Market Cap: 99.16M JOD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	47.96M	7.31M	17.98%
Dec 31, 2024	40.65M	-2.48M	-5.74%
Dec 31, 2023	43.13M	-3.91M	-8.31%
Dec 31, 2022	47.03M	1.56M	3.44%
Dec 31, 2021	45.47M	9.62M	26.82%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error